Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.
Elucida Oncology Address
1 Deer Park Drive Monmouth Junction, NJ United States
Elucida Oncology Email
Past Companies
Elucida Oncology, Inc.Vice President, Technology and CMC
Elucida Oncology, Inc.Head, Materials Science and Production
Elucida Oncology, Inc.Principal Scientist, Materials Development